Home LiteratureArticle Details
PMID: 8371353 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac.

Journal of virology ·Vol. 67 ·No. 10 ·1993-10-00 ·Pages 6047-55

Marthas ML, Ramos RA, Lohman BL, Van Rompay KK, Unger RE, Miller CJ, Banapour B, Pedersen NC, Luciw PA

Abstract

To identify viral determinants of simian immunodeficiency virus (SIV) virulence, two pairs of reciprocal recombinants constructed from a pathogenic (SIVmac239) and a nonpathogenic (SIVmac1A11) molecular clone of SIV were tested in rhesus macaques. A large 6.2-kb fragment containing gag, pol, env, and the regulatory genes from each of the cloned (parental) viruses was exchanged to produce one pair of recombinant viruses (designated SIVmac1A11/239gag-env/1A11 and SIVmac239/1A11gag-env/239 to indicate the genetic origins of the 5'/internal/3' regions, respectively, of the virus). A smaller 1.4-kb fragment containing the external env domain of each of the parental viruses was exchanged to create the second pair (SIVmac1A11/239env/1A11 and SIVmac239/1A11env/239) of recombinant viruses. Each of the two parental and four recombinant viruses was inoculated intravenously into four rhesus macaques, and all 24 animals were viremic by 4 weeks postinoculation (p.i.). Virus could not be isolated from peripheral blood mononuclear cells (PBMC) of any animals infected with SIVmac1A11 after 6 weeks p.i. but was consistently isolated from all macaques inoculated with SIVmac239 for 92 weeks p.i. Virus isolation was variable from animals infected with recombinant viruses; SIVmac1A11/239gag-env/1A11 and SIVmac239/1A11env/239 were isolated most frequently. Animals inoculated with SIVmac239 had 10 to 100 times more virus-infected PBMC than those infected with recombinant viruses. Three animals infected with SIVmac239 died with simian AIDS (SAIDS) during the 2-year observation period after inoculation, and the fourth SIVmac239-infected animal had clinical signs of SAIDS. Two animals infected with recombinant viruses died with SAIDS; one was infected with SIVmac239/1A11gag-env/239, and the other was infected with SIVmac1A11/239gag-env/1A11. The remaining 18 macaques remained healthy by 2 years p.i., and 13 were aviremic. One year after inoculation, peripheral lymph nodes of some of these healthy, aviremic animals harbored infected cells. All animals seroconverted within the first few weeks of infection, and the magnitude of antibody response to SIV was proportional to the levels and duration of viremia. Virus-suppressive PBMC were detected within 2 to 4 weeks p.i. in all animals but tended to decline as viremia disappeared. There was no association of levels of cell-mediated virus-suppressive activity and either virus load or disease progression. Taken together, these results indicate that differences in more than one region of the viral genome are responsible for the lack of virulence of SIVmac1A11.

Related Genes
MeSH Terms
Animals Antibodies, Viral/blood Genes, Regulator Genes, Viral Genes, env Genes, gag Genes, pol Macaca mulatta Polymerase Chain Reaction/methods Simian Acquired Immunodeficiency Syndrome/blood,immunology,microbiology Simian Immunodeficiency Virus/genetics,pathogenicity,physiology Vaccines, Attenuated Viral Vaccines/immunology Virulence/genetics Virus Replication
Chemicals
Antibodies, Viral Vaccines, Attenuated Viral Vaccines
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Marthas M L
California Regional Primate Research Center, University of California, Davis 95616.
Ramos R A
Lohman B L
Van Rompay K K
Unger R E
Miller C J
Banapour B
Pedersen N C
Luciw P A
References (39)
39 references, click to expand
  1. Thymotropism of murine leukemia virus is conferred by its long terminal repeat.
    Proc Natl Acad Sci U S A. 1983 Jul;80(14):4203-7 PMID: 6308605
  2. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.
    Science. 1992 Dec 18;258(5090):1938-41 PMID: 1470917
  3. Mapping the viral sequences conferring leukemogenicity and disease specificity in Moloney and amphotropic murine leukemia viruses.
    J Virol. 1984 Nov;52(2):448-56 PMID: 6092670
  4. A 1.6-kilobase-pair fragment in the genome of the ts1 mutant of Moloney murine leukemia virus TB that is associated with temperature sensitivity, nonprocessing of Pr80env, and paralytogenesis.
    J Virol. 1985 May;54(2):364-73 PMID: 3989910
  5. Sequences in the gag-pol-5'env region of avian leukosis viruses confer the ability to induce osteopetrosis.
    Virology. 1985 Aug;145(1):94-104 PMID: 2409672
  6. Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences.
    J Virol. 1985 Sep;55(3):862-6 PMID: 2991605
  7. Sequences near the 5' long terminal repeat of avian leukosis viruses determine the ability to induce osteopetrosis.
    J Virol. 1986 Jul;59(1):45-9 PMID: 2423704
  8. The neurovirulent determinants of ts1, a paralytogenic mutant of Moloney murine leukemia virus TB, are localized in at least two functionally distinct regions of the genome.
    J Virol. 1986 Jul;59(1):59-65 PMID: 3712556
  9. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.
    Science. 1988 Jan 29;239(4839):487-91 PMID: 2448875
  10. Pathogenic and host range determinants of the feline aplastic anemia retrovirus.
    Proc Natl Acad Sci U S A. 1988 Apr;85(8):2758-62 PMID: 2833751
  11. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection.
    J Virol. 1988 Aug;62(8):2557-68 PMID: 2839686
  12. Long terminal repeat (LTR) sequences, env, and a region near the 5' LTR influence the pathogenic potential of recombinants between Rous-associated virus types 0 and 1.
    J Virol. 1988 Sep;62(9):3431-7 PMID: 2841495
  13. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.
    J Virol. 1988 Dec;62(12):4691-6 PMID: 2846880
  14. Influence of env and long terminal repeat sequences on the tissue tropism of avian leukosis viruses.
    J Virol. 1988 Dec;62(12):4828-31 PMID: 2846895
  15. Retrovirus-induced murine motor neuron disease: mapping the determinant of spongiform degeneration within the envelope gene.
    Proc Natl Acad Sci U S A. 1989 May;86(10):3896-900 PMID: 2542954
  16. Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus.
    J Med Primatol. 1989;18(3-4):311-9 PMID: 2547965
  17. Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM).
    AIDS Res Hum Retroviruses. 1989 Aug;5(4):397-409 PMID: 2765298
  18. Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals.
    J Virol. 1990 May;64(5):2290-7 PMID: 2157886
  19. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.
    Science. 1990 Jun 1;248(4959):1109-12 PMID: 2160735
  20. The simian immunodeficiency viruses.
    Annu Rev Immunol. 1990;8:557-78 PMID: 2188674
  21. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV.
    J Virol. 1990 Aug;64(8):3694-700 PMID: 2164591
  22. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus.
    AIDS Res Hum Retroviruses. 1990 Nov;6(11):1221-31 PMID: 2078405
  23. Disease progression and viral genome variants in experimental feline leukemia virus-induced immunodeficiency syndrome.
    J Acquir Immune Defic Syndr. 1991;4(6):547-57 PMID: 1850796
  24. Importance of the nef gene for maintenance of high virus loads and for development of AIDS.
    Cell. 1991 May 17;65(4):651-62 PMID: 2032289
  25. In vitro macrophage tropism of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac).
    Virology. 1991 Jul;183(1):12-9 PMID: 1711254
  26. Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS.
    Am J Pathol. 1991 Jul;139(1):29-35 PMID: 1853937
  27. Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac.
    J Virol. 1991 Nov;65(11):5798-805 PMID: 1920617
  28. Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism.
    J Virol. 1991 Nov;65(11):5921-7 PMID: 1920621
  29. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus.
    J Virol. 1993 Feb;67(2):902-12 PMID: 8380472
  30. Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection.
    Antimicrob Agents Chemother. 1992 Nov;36(11):2381-6 PMID: 1489181
  31. Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant.
    J Virol. 1993 May;67(5):2466-74 PMID: 8474153
  32. Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry.
    J Virol. 1993 May;67(5):2807-14 PMID: 7682627
  33. Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay.
    J Clin Microbiol. 1991 Oct;29(10):2187-92 PMID: 1939569
  34. Complex determinants of macrophage tropism in env of simian immunodeficiency virus.
    J Virol. 1992 Apr;66(4):2067-75 PMID: 1548752
  35. Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac).
    AIDS Res Hum Retroviruses. 1992 Mar;8(3):395-402 PMID: 1571198
  36. The nef gene of simian immunodeficiency virus SIVmac1A11.
    J Virol. 1992 Sep;66(9):5432-42 PMID: 1501282
  37. Detection of simian immunodeficiency virus DNA in macrophages from infected rhesus macaques.
    J Med Primatol. 1992 Feb-May;21(2-3):74-81 PMID: 1433270
  38. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV.
    J Med Primatol. 1992 Feb-May;21(2-3):99-107 PMID: 1433273
  39. Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses.
    Proc Natl Acad Sci U S A. 1983 Jul;80(14):4408-11 PMID: 6308622
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1993-10-00
Pages
6047-55
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC238025
Subset
IM
Grants
NCRR NIH HHS · 5P51-RR00169 · United States
NIAID NIH HHS · AI31383 · United States
NHLBI NIH HHS · HL43609 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com